Transparent Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: people who want transparent, upfront monthly pricing on compounded semaglutide or tirzepatide injections
Transparent Meds is a solid telehealth option with balanced features and pricing.
then $229/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Transparent Meds is an online GLP-1 weight-care service that connects you with licensed medical providers and leads with upfront pricing: compounded weekly injections of semaglutide at an intro $149/month (reg $229) and tirzepatide at $249/month (reg $349), prescribed after a quiz and clinician review. It is HIPAA-compliant with a LegitScript-style seal and a transparency-first brand, but uses a connector model, doesn't name its compounding pharmacy, and doesn't publish the states it serves; displayed prices are illustrative first-month program fees.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Transparent Meds
Direct Meds
Best for: listed for transparent disclosure — see FDA warning and BBB complaint pattern before considering
Editorial score · methodology
Maximus
Best for: men seeking compounded GLP-1 alongside testosterone optimization
Editorial score · methodology
Sesame Care
Best for: Brand-name GLP-1s (Wegovy, Zepbound) at LillyDirect/NovoCare cash prices — no compounding
Editorial score · methodology
Transparent Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo (Intro first-month price $149 (regular $229); compounded GLP-1 weekly injection when prescribed after clinician review)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Transparent Meds
Each dimension is scored algorithmically from Transparent Meds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.9/10At $229/mo, Transparent Meds runs about 36% above the $169 median for GLP-1 providers, and the first-month promo drops to $149. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.4/10Transparent Meds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.7/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-13).
Accessibility10%
6.4/10Transparent Meds's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.2/10Transparent Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Transparent Meds review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Transparent Meds
We walked Transparent Meds’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a secure online intake in minutes; a licensed clinician reviews your health history and goals.
- 2If GLP-1 (or NAD+) therapy fits, you receive a personalized plan with clear pricing and no surprise fees at checkout.
- 3Medication ships discreetly from licensed U.S. pharmacies with tracking.
- 4Get free, unlimited follow-ups with a healthcare professional and refill/dose adjustments.
- Monthly prices are shown upfront on the homepage before intake: Semaglutide $99/mo (from $229), Tirzepatide $199/mo (from $349); also NAD+ $149/mo.
- Emphasizes transparent pricing with no hidden fees and $0 surprise membership fees.
- Pause or cancel anytime is stated; free shipping on all orders.
- Site is a JS app that renders little to plain fetchers; content confirmed via Chrome.
- Also offers non-GLP-1 programs (NAD+, Tesamorelin), so it is not GLP-1-exclusive.
GLP-1 medications Transparent Meds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Intro first-month price $149 (regular $229); compounded GLP-1 weekly injection when prescribed after clinician review
Intro first-month price $249 (regular $349); compounded dual GIP/GLP-1 weekly injection when prescribed
Ready to get started?
Plans and promotions change often — check Transparent Meds's current pricing and active discounts before you decide.
What we like
- Transparent, upfront monthly pricing — intro $149/mo for compounded semaglutide and $249/mo for tirzepatide (regular $229 / $349)
- Clean, modern telehealth experience with a quick eligibility quiz and clinician review before any prescription
- HIPAA-compliant and displays a LegitScript-style verification seal
Watch-outs
- Headline prices are intro first-month fees — the regular monthly cost is higher ($229 semaglutide, $349 tirzepatide)
- Connector model that pairs you with licensed providers; it doesn't name its compounding pharmacy
- Doesn't publish the states it serves, so confirm availability before signing up
- Compounded semaglutide and tirzepatide injections only — no oral, brand-name, or insurance options
Is Transparent Meds worth it? Our verdict
Transparent Meds positions itself around one thing: people who want transparent, upfront monthly pricing on compounded semaglutide or tirzepatide injections. New patients start at $149 in month one, but the price settles at $229/month after that — so the headline is a trial offer, not the standing rate. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
On top of the prescription itself, Transparent Meds points to Weekly injection, Transparent upfront pricing, and Intro pricing.
How much Transparent Meds actually costs
- semaglutide — $149 first month, then $229/month
- tirzepatide — $249 first month, then $349/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so Transparent Meds's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, MadeMed runs semaglutide and tirzepatide from $219/month — worth pricing against Transparent Meds before you commit.
Medications: what Transparent Meds prescribes
Transparent Meds prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today.
Who Transparent Meds is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. We explain how we weigh medical oversight and compliance in our scoring methodology.
Bottom line
Transparent Meds is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $149 intro price steps up to $229/month. Use the first month to confirm the medication works for you, then re-check the ongoing math before you settle in.
The Bottom Line
Transparent Meds is a solid telehealth option with balanced features and pricing.
Ready to start with Transparent Meds?
Starting at $149/month. See current pricing and start your free consultation.
Transparent Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Transparent Meds review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Transparent Meds's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.